Use of medication for challenging behaviour in people with intellectual disability

Affiliation

• ¹ Gyles Glover, MSc, MD, FRCPsych, FPPH, Co-Director, Learning Disabilities Team, Public Health England; Sarah Bernard, MD, FRCPsych, DRCOG, Child and Adolescent Learning Disability Service, South London and Maudsley NHS Foundation Trust; David Branford, PhD, FRPharmS, FCMHP, Chairman, English Pharmacy Board, Royal Pharmaceutical Society; Anthony Holland, MPhil, MRCP, FRCPsych, Diploma in Clinical Genetics, Health Foundation Chair in Learning Disabilities, Academic Department of Psychiatry, University of Cambridge; Andre Strydom, MSc, PhD, MRCPsych, Reader in Intellectual Disabilities, Mental Health Sciences Unit, University College London, UK.